Wedbush Downgrades Ironwood Pharmaceuticals (IRWD) to Underperform

April 24, 2013 8:05 AM

Wedbush downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Neutral to Underperform with a price target of $12.00 (from $13.00).

"Ongoing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found